Trial Profile
Efficacy and safety of afatinib in patients with advanced or metastatic non-small cell lung cancer: A compassionate use program
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 05 Aug 2016
Price :
$35
*
At a glance
- Drugs Afatinib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 05 Aug 2016 New trial record